Literature DB >> 31902071

Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?

Robert Battat1,2, Parambir S Dulai1, Christopher Ma2,3, Vipul Jairath2,4,5, Brian G Feagan2,4,5, William J Sandborn1,2, Reena Khanna6.   

Abstract

Note: This statement is mandatory. Please provide.

Entities:  

Keywords:  Clinical trial; Endpoints; Outcomes; Remission; Ulcerative colitis

Year:  2020        PMID： 31902071     DOI： 10.1007/s11938-019-00259-w

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN： 1092-8472


  71 in total

1.  Physician assessment of ulcerative colitis activity correlates poorly with endoscopic disease activity.

Authors:  Miguel Regueiro; Joseph Rodemann; Kevin E Kip; Melissa Saul; Jason Swoger; Leonard Baidoo; Marc Schwartz; Arthur Barrie; David Binion
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

2.  Development and validation of a histological index for UC.

Authors:  Mahmoud H Mosli; Brian G Feagan; Guangyong Zou; William J Sandborn; Geert D'Haens; Reena Khanna; Lisa M Shackelton; Christopher W Walker; Sigrid Nelson; Margaret K Vandervoort; Valerie Frisbie; Mark A Samaan; Vipul Jairath; David K Driman; Karel Geboes; Mark A Valasek; Rish K Pai; Gregory Y Lauwers; Robert Riddell; Larry W Stitt; Barrett G Levesque
Journal:  Gut       Date:  2015-10-16       Impact factor: 23.059

3.  Inter-observer agreement in endoscopic scoring systems: preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD).

Authors:  Marco Daperno; Michele Comberlato; Fabrizio Bossa; Livia Biancone; Andrea G Bonanomi; Andrea Cassinotti; Rocco Cosintino; Giovanni Lombardi; Roberto Mangiarotti; Alfredo Papa; Roberta Pica; Fernando Rizzello; Renata D'Incà; Ambrogio Orlando
Journal:  Dig Liver Dis       Date:  2014-08-19       Impact factor: 4.088

4.  Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.

Authors:  Neeraj Narula; Farhad Peerani; Joseph Meserve; Gursimran Kochhar; Khadija Chaudrey; Justin Hartke; Prianka Chilukuri; Jenna Koliani-Pace; Adam Winters; Leah Katta; Eugenia Shmidt; Robert Hirten; David Faleck; Malav P Parikh; Diana Whitehead; Brigid S Boland; Siddharth Singh; Sashidhar Varma Sagi; Monika Fischer; Shannon Chang; Morris Barocas; Michelle Luo; Karen Lasch; Matthew Bohm; Dana Lukin; Keith Sultan; Arun Swaminath; David Hudesman; Nitin Gupta; Bo Shen; Sunanda Kane; Edward V Loftus; Corey A Siegel; Bruce E Sands; Jean-Frederic Colombel; William J Sandborn; Parambir S Dulai
Journal:  Am J Gastroenterol       Date:  2018-06-27       Impact factor: 10.864

5.  Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02.

Authors:  C B Scott; J S Nelson; N C Farnan; W J Curran; K J Murray; A J Fischbach; L E Gaspar; D F Nelson
Journal:  Cancer       Date:  1995-07-15       Impact factor: 6.860

6.  Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements.

Authors:  Alain Bitton; Donald Buie; Robert Enns; Brian G Feagan; Jennifer L Jones; John K Marshall; Scott Whittaker; Anne M Griffiths; Remo Panaccione
Journal:  Am J Gastroenterol       Date:  2011-11-22       Impact factor: 10.864

7.  Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis.

Authors:  P D R Higgins; M Schwartz; J Mapili; I Krokos; J Leung; E M Zimmermann
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

8.  Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.

Authors:  Maurice W M D Lutgens; Martijn G H van Oijen; Geert J M G van der Heijden; Frank P Vleggaar; Peter D Siersema; Bas Oldenburg
Journal:  Inflamm Bowel Dis       Date:  2013 Mar-Apr       Impact factor: 5.325

9.  Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Ellen J Scherl; Ronald Pruitt; Glenn L Gordon; Mark Lamet; Audrey Shaw; Shirley Huang; Shadreck Mareya; William P Forbes
Journal:  Am J Gastroenterol       Date:  2009-04-21       Impact factor: 10.864

10.  Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study.

Authors:  C N Bernstein; F Shanahan; P A Anton; W M Weinstein
Journal:  Gastrointest Endosc       Date:  1995-09       Impact factor: 9.427
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.